Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has announced the Unaudited Standalone results for the Quarter ended December 31, 2016. The Company has posted a net loss of Rs (1626.60) million for the quarter ended December 31, 2016 as compared to net loss of Rs (1422.70) million for the quarter ended December 31, 2015. Total Income has increased from Rs 19283.90 million for the quarter ended December 31, 2015 to Rs 20128.10 million for the quarter ended December 31, 2016. The company also announced the Unaudited Consolidated results for the Quarter ended December 31, 2016. The Group has posted a net profit after taxes, non-controlling interest and share of profit of associates & joint ventures of Rs 14718.20 million for the quarter ended December 31, 2016 as compared to Rs 15448.50 million for the quarter ended December 31, 2015. Total Income has increased from Rs 72952.00 million for the quarter ended December 31, 2015 to Rs 80348.10 million for the quarter ended December 31, 2016.

The above information is a part of company’s filings submitted to BSE.